{"name":"Public Health Service of Amsterdam","slug":"public-health-service-of-amsterdam","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Fosfomycin Oral Suspension","genericName":"Fosfomycin Oral Suspension","slug":"fosfomycin-oral-suspension","indication":"Uncomplicated urinary tract infections (acute cystitis)","status":"marketed"},{"name":"Gentamicin Sulfate, Injectable","genericName":"Gentamicin Sulfate, Injectable","slug":"gentamicin-sulfate-injectable","indication":"Serious gram-negative bacterial infections (sepsis, urinary tract infections, respiratory tract infections)","status":"phase_3"}]}],"pipeline":[{"name":"Fosfomycin Oral Suspension","genericName":"Fosfomycin Oral Suspension","slug":"fosfomycin-oral-suspension","phase":"marketed","mechanism":"Fosfomycin inhibits bacterial cell wall synthesis by inactivating the enzyme enolpyruvate transferase, preventing peptidoglycan cross-linking.","indications":["Uncomplicated urinary tract infections (acute cystitis)","Bacterial infections susceptible to fosfomycin"],"catalyst":""},{"name":"Gentamicin Sulfate, Injectable","genericName":"Gentamicin Sulfate, Injectable","slug":"gentamicin-sulfate-injectable","phase":"phase_3","mechanism":"Gentamicin sulfate is an aminoglycoside antibiotic that binds to bacterial 30S ribosomal subunits and inhibits protein synthesis, leading to bacterial cell death.","indications":["Serious gram-negative bacterial infections (sepsis, urinary tract infections, respiratory tract infections)","Gram-positive infections in combination therapy","Empiric therapy for suspected aerobic gram-negative infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQMkNKVkhLTzhKbXRRRFZtQWh1LUdYYkxZUUhPR2NQd0xQSU50TVUwRGQwaS1Ib19wRHZJeC00M2sxckpfOWgyazhKWGJndWtOR3dOb0tSM0oxWERTOWxSMlF3UUk2TWVXb0dPRFFSNXo2alIzTFRGNkpUeFBxcXZoNFROQ096WXFIQ2NXdGw1YkZUQ3ByN1BQZnhnTjltUkFNWW9n?oc=5","date":"2026-03-23","type":"trial","source":"The Pharma Letter","summary":"Maximize NHS data to boost UK clinical trials, report says - The Pharma Letter","headline":"Maximize NHS data to boost UK clinical trials, report says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSjVzUUZ0MEg2OVcxWnlpbkQ5c3pZVC1DenE3ZXZzTUgxNHFSVVhMb294NkVkMmpiMU9fNEtyaXhGQU9ROE9EQ2hNWDlfQTFySEtSdjV4LXkwMi0wZ0tfN0l2endvSEJxYWxLajV4cVVMRVJ0bW9MQWtCdUJ0eEo3dXZuNVZBMmF1T0RTQ1EzVlVKUWoxM2c?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034 - Fortune Business Insights","headline":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPOUt2emFONWxxa2ZhRDV6SjNWeXY0NTI3Mm5rZlJpbEVwSVF1c2kxYmNtLWxaRzNGRkRnYUkycU9kRklVX1NxZW5iZlJVNUtkZXZWRDdPbFVMdjZ5cHVGTnZ2a0ZrYjNjRGpLemZlMEpQajBIcjh3QV95YnZUUC1MWWFMWnVVdw?oc=5","date":"2026-03-12","type":"pipeline","source":"Ipsos","summary":"[EVENT] Taste the Future | The Balancing Act of Food, Health & Pharma - Ipsos","headline":"[EVENT] Taste the Future | The Balancing Act of Food, Health & Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPMmVkMzhJVUFHak1BNi1RWmdhdDFKOU90SlJyMGwwdS1rLUwwU193Mmp0Mk5qeHhtQndkUXJQZHdlNnV6U1BEQ3FGcDlCWk9zRFRFNG5XNVZtWlZLMmhPQ254cWViTWZkcHFsOGUwclBVMUVJel9adjhCRXBSZkIzSW45UTlHb1dKbEZJSXZ3UGR3T2N2M1lOQkxmejdBUzlxRHlxcExRNU9Za2ZUVU5CNFpYZnRJN25Hamh0R2RIM1VWLWRNY2RLc05YSQ?oc=5","date":"2026-02-18","type":"pipeline","source":"Norton Rose Fulbright","summary":"Louisiana 340B contract pharmacy law upheld by Fifth Circuit - Norton Rose Fulbright","headline":"Louisiana 340B contract pharmacy law upheld by Fifth Circuit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNSHRjOE80enZ6QTQ5d0Y1NXdxMzg3TTJDX1c3ZC1MWFVrUEhFREpoWW40NGVnS09qREs5ODI4aFN1UG8tTmx2SUJaZGYyb1BfWnduLVhiR0ZRb2s5Mm45M1V5TlFncGduS0thRXJBSzQ1R3F3aUNwZlJ6MGVyc3RFYjNMbnBNcjBIcl9QdVhR?oc=5","date":"2026-01-19","type":"pipeline","source":"Frontiers","summary":"Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education - Frontiers","headline":"Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOcXd1cUdtYTJKWGhTZmtrTnJjcFc4X0tpUTA2WmZSNlVqM29nODczWG1zRVJDdUNKT2t5Z1ZaaGgwMmQwcFFUbXlMY3A1YkhHQ2M3RERGZUJGNmNreUk3OGdVaFFBSXV5UVQtdWpERENTNEJteWtUVllBY0dUWktFcUZVVlRLS0FWeGwyazNSdmgxNTQt?oc=5","date":"2025-11-17","type":"regulatory","source":"Frontiers","summary":"Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines - Frontiers","headline":"Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNeXhidS00bzdxaHgxckxucnhqY0ZYU2ZzZG92dkRxNWZOdjloVFJteGpyLW16VEpZSUNQT0ozUTBZd1RINkIwdUpoZl9lUEV3a1EtZ3lIaUdoVVRpQ3hXUk5LanBqczUyaWpqbXpJa0xYRHpiQmxEdFYxX1dmczc0UG5ueXBLOEI0RVlDUlE3RjFGTTBRM0kydHJ6WlZOSjRYLW5FZkV6ejhVcE5PaTlYdjN3cmFMTkdSQm9YeUF4MlFnSXFFaXdReWlHRGJaaHhlSGxTcEh5WmRFbkphb3BDcTg2UFJMelJTVWEzbGhGOXdaWFRDUEtaa3U3V1B0a0FEM1luVkFzd0JLZDNselhNb2RLSUJYTTk3UzlDNWpubXJBWUNHdGktOG5RUURWRDltcF9pdFRiSTZDcVJha1JKam9hNGQ3WWhjcEE?oc=5","date":"2025-08-21","type":"pipeline","source":"PR Newswire","summary":"Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - PR Newswire","headline":"Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOdHVFcFdFaFJWaVVmUDdHNEdmaUNYVGtpSVZEdXoyY2x0TDFFVEF5bXVQSXRNMzcyQkxPQW51S3MwSkJ4dmgxelo4TGFJREtocTVPSE9PZUNJc25QRXVPQzFMb3otcDZmS3ZiN1kzRkowU19YVDlZbmdxMDhNX08yeER0QVJPX1ppOW50OUhBOUFLWU1UdHc?oc=5","date":"2025-08-04","type":"pipeline","source":"The Medical Journal of Australia","summary":"The need to urgently rethink coronary heart disease - The Medical Journal of Australia","headline":"The need to urgently rethink coronary heart disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxORGtFaUdFZEY0ekltTHM0eHV0ZkJUVkt4SGVKLUExZXRaWWdqM3Joc1FRS1h3b2ZSSmtmZ0ZIN01zVWd4QUo4bWszVDFNOXNmZWpNT3RTLS1oTE4wOWhSeG5keUJNVUkzUUdMVG10RExBOG5zMXA1UmVfcUlQUzRrVDNOMVpmTnJ3OF9RcDQzbjdZTWFUTXZ2QUFZZGp5UkpC?oc=5","date":"2025-07-07","type":"pipeline","source":"CIDRAP","summary":"Dutch survey finds informal use of doxyPEP is rising - CIDRAP","headline":"Dutch survey finds informal use of doxyPEP is rising","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNak50VHNjNUU3NXlqVGVfa1YxR1NtSkJ3dnBoeXlXWWhKVHBkRElOZ3ZSUHNNVlJlRHpmdHlad0EyZS10SXdmaV9PNTltRmlfNDBjUWdZMHZyTjdNZExGdGRONm5pckd6NzFkQi15d3RyRHNFc3dtUl8yVU8wLTVOWGxTQkduQUhoUnVaa05MVkg1Ri1IaDNrTXRmdWhWX3h6aW5TTUpLWmNPRkQ4ZTFueFJnTXFHZXp1d3NqSlg3bnBpYldxQXc?oc=5","date":"2025-05-29","type":"pipeline","source":"WWNO","summary":"Going Dutch: Harm reduction is embraced in the Netherlands but struggles in the US - WWNO","headline":"Going Dutch: Harm reduction is embraced in the Netherlands but struggles in the US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSDkxVGIzZmRKYVBsaklBZDJtRmROVTd6bFlBYjg4dFN4b3RTNks4eHBNOFU5Ykc1SUlVWkFUMGdpd3lQblh5aHdvR2F0Rk52T1JoZ1JISWJ2YWJMVElsSkZCZTJpTnZldkxBOHpZT2kwci1EY0I5NjZWZWNhVkZ6WVVRal81a2NQT0o3RjBFT0xQZnV6ZW1mb2RRVHh3dWFEMVhQX0drZFIzVDlhdnh6MEJlT2JIcklzZ25YV0hxYlp6SzBwOXZtY2RIdW9tR01Ic25Xb2NheHk?oc=5","date":"2025-05-14","type":"pipeline","source":"Reuters","summary":"European governments scramble to interpret Trump's new drug pricing order - Reuters","headline":"European governments scramble to interpret Trump's new drug pricing order","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}